cbdMD, Inc. will hold its 2026 Annual Meeting of Shareholders on March 30, 2026. Shareholders will vote on several key proposals during the meeting, including the election of directors, the ratification of the appointment of Cherry Bekaert LLP, approval of a reverse stock split proposal, and approval of the Series B 20% Issuance Proposal.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-002596), on February 02, 2026, and is solely responsible for the information contained therein.
Comments